Mesalamine
NDC 65162-360, Mesalamine, tablet, delayed release, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-360
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215067
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65162-360 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE800 mg/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-360-18 | 65162036018 | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (65162-360-18) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/00f77203-3615-47e8-ae25-6e1cf8a2a00aNADAC price for package 65162036018
GET /v1/drugs/nadac/65162036018
Use it
Look up 65162-360 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-360 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-360. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.